PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
1.75%
Positive revenue growth while 3141.T is negative. John Neff might see a notable competitive edge here.
1.77%
Positive gross profit growth while 3141.T is negative. John Neff would see a clear operational edge over the competitor.
4.04%
Positive EBIT growth while 3141.T is negative. John Neff might see a substantial edge in operational management.
15.41%
Positive operating income growth while 3141.T is negative. John Neff might view this as a competitive edge in operations.
13.61%
Positive net income growth while 3141.T is negative. John Neff might see a big relative performance advantage.
13.59%
Positive EPS growth while 3141.T is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
13.59%
Positive diluted EPS growth while 3141.T is negative. John Neff might view this as a strong relative advantage in controlling dilution.
0.02%
Share reduction more than 1.5x 3141.T's 0.05%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
0.02%
Slight or no buyback while 3141.T is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Negative OCF growth while 3141.T is at 0.87%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-100.00%
Negative FCF growth while 3141.T is at 0.87%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
160.73%
Similar 10Y revenue/share CAGR to 3141.T's 156.86%. Walter Schloss might see both firms benefiting from the same long-term demand.
56.92%
5Y revenue/share CAGR similar to 3141.T's 57.84%. Walter Schloss might see both companies benefiting from the same mid-term trends.
34.46%
3Y revenue/share CAGR 1.25-1.5x 3141.T's 29.21%. Bruce Berkowitz might see better product or regional expansions than the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
138.65%
Net income/share CAGR above 1.5x 3141.T's 65.83% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
37.21%
5Y net income/share CAGR 1.25-1.5x 3141.T's 30.40%. Bruce Berkowitz would check if a better product mix or cost discipline explains the gap.
-32.24%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
331.44%
10Y equity/share CAGR above 1.5x 3141.T's 172.28%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
86.25%
5Y equity/share CAGR 1.25-1.5x 3141.T's 68.01%. Bruce Berkowitz confirms if reinvested profits or buybacks explain the superior buildup.
35.83%
3Y equity/share CAGR similar to 3141.T's 34.51%. Walter Schloss sees both having parallel profitability or reinvestment over 3 years.
No Data
No Data available this quarter, please select a different quarter.
166.67%
Dividend/share CAGR of 166.67% while 3141.T is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
No Data
No Data available this quarter, please select a different quarter.
9.04%
Our AR growth while 3141.T is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
-3.29%
Inventory is declining while 3141.T stands at 7.77%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-1.36%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
1.52%
BV/share growth above 1.5x 3141.T's 0.36%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-6.02%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
-0.62%
We cut SG&A while 3141.T invests at 2.46%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.